发明名称 DIRECTED CYTOLYSIS OF TARGET CELLS, AGENTS AND COMPOSITIONS CAUSING CYTOLYSIS, AND COMPOUNDS THAT CAN BE USED TO PRODUCE THE AGENTS
摘要 Target cells (A) are inactivated in presence of T cells by contacting both cell types with a superantigen (Sag) in presence of an immune modulator (IM). The new feature is that at least one of SAg and IM is present as a conjugate between a 'free' superantigen and a component (T) that targets the conjugate to (A). Also new are: (1) Sag conjugates of formula (T)x(Sag)y(IM)z (I), Sag, IM (not a superantigen) and T are linked via organic linkers, same or different, x, y and z are integers typically 0-10, provided that y and at least one of x and z must be greater than zero; (2) targeted IM conjugates of formula (T)x(Sag)y(IM')z (V), IM' = IM in which affinity for lymphocyte receptors or rate of internalisation when bound to this receptor has been reduced, e.g. by mutation; here z and at least one of x and y must be greater than zero; (3) DNA (II) encoding an Sag and an IM, especially interleukin-2 (IL-2), that is not an Sag.
申请公布号 HU0002977(A2) 申请公布日期 2000.12.28
申请号 HU20000002977 申请日期 1998.07.02
申请人 PHARMACIA and UPJOHN AB 发明人 ABRAHMSEN, LARS;DOHLSTEN, MIKAEL;FORSBERG, GOERAN;KALLAND, TERJE;LANDO, PETER;SOEGAARD, MORTEN
分类号 A61K;A61K47/55;A61K47/68 主分类号 A61K
代理机构 代理人
主权项
地址